Atlas Trials

Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia

Clinical trial NCT03686345 · TERMINATED

Trial details

NCT number
NCT03686345
Sponsor
Niguarda Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
Start date
2018-07-01
Primary completion
2023-06-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.